JW Holdings signs supply agreement of ‘ertapenem’ ingredients with Indian Grand Pharma

JW Holdings will enter advanced markets, such as the U.S. Canada, through exports of ‘ertapenem’ ingredients, a next-generation antibiotic.

The company announced on the 24^th that it signed an agreement to supply ‘ertapenem’ ingredients worth of the total USD 26 million and exclusively sell its finished products in the U.S. and Canada with Indian Grand Pharma.

Under the agreement, JW Holdings ...